标题
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-11-17
DOI
10.1038/s41467-017-01850-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The PIDDosome activates p53 in response to supernumerary centrosomes
- (2017) Luca L. Fava et al. GENES & DEVELOPMENT
- CHK1 as a therapeutic target to bypass chemoresistance in AML
- (2016) Laure David et al. Science Signaling
- Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
- (2016) Kumar Sanjiv et al. Cell Reports
- CHK1 as a therapeutic target to bypass chemoresistance in AML
- (2016) Laure David et al. Science Signaling
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses
- (2015) Rebecca C. Burgess et al. CELL
- Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
- (2015) Enrico Derenzini et al. Oncotarget
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Wnt-driven intestinal tumourigenesis is suppressed by Chk1 deficiency but enhanced by conditional haploinsufficiency
- (2013) K R Greenow et al. ONCOGENE
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
- (2012) Jian Hong et al. JOURNAL OF CLINICAL INVESTIGATION
- An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation
- (2012) Andres J. López-Contreras et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
- (2011) A. Hoglund et al. CLINICAL CANCER RESEARCH
- Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
- (2011) Luis I. Toledo et al. Molecular Oncology
- Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
- (2011) Matilde Murga et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
- (2011) P T Ferrao et al. ONCOGENE
- Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis
- (2011) L M Tho et al. ONCOGENE
- Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
- (2010) Hiroyuki Niida et al. EMBO JOURNAL
- Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
- (2010) Szilvia Solyom et al. Familial Cancer
- Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation
- (2010) V. Labi et al. GENES & DEVELOPMENT
- Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53
- (2010) T Fishler et al. ONCOGENE
- Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis
- (2010) Nathan C. Boles et al. PLoS One
- Novel Positive Feedback Loop between Cdk1 and Chk1 in the Nucleus during G2/M Transition
- (2009) Masato Enomoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation
- (2009) K R Greenow et al. ONCOGENE
- The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis
- (2009) S. Peddibhotla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control
- (2008) D. Wilsker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now